IMPACT FACTOR
2023
1.5
|
MNiSW
20*
|
Indexed in:
ESCI
Web of Science
Clarivate Analytics
|
JCI
0.31
Journal Citation Indicator
|
CiteScore 2023
2.8
|
NEW Guidelines for Authors!
* The
current MNiSW score is temporary and results from the decision of the Minister
of Science and Higher Education to withdraw scores from all journals that
received an increase in score in 2023. The decision is the result of the need
to develop a new scoring system. However, all articles published in 2023 are
awarded 200 MNiSW points, and the actual score for 2024 will be determined at
the end of the year. * Obecna
punktacja MEiN ma charakter tymczasowy i wynika z decyzji Ministra Nauki i
Szkolnictwa Wyższego o wycofaniu punktacji wszystkim czasopismom, które w 2023
r. uzyskały podwyższenie punktacji. Decyzja ta wynika z konieczności
opracowania nowego systemu punktacji. Natomiast wszystkie artykuły opublikowane
w roku 2023 otrzymują 200 punktów MNiSW, a ostateczna punktacja za rok 2024
zostanie ustalona na koniec roku.
Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.
Indexed in PubMed and Web of Science Core Collection
3/2018
vol. 4
|
|
Special paper
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
Krzysztof Tomasiewicz,
Robert Flisiak,
Waldemar Halota,
Jerzy Jaroszewicz,
Dariusz Lebensztejn,
Wojciech Lisik,
Piotr Małkowski,
Małgorzata Pawłowska,
Anna Piekarska,
Krzysztof Simon,
Olga Tronina
Clin Exp HEPATOL 2018; 4, 3: 153–157
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78118
Review paper
Immunodeficiency caused by cirrhosis
Ewelina Tuchendler,
Paweł K. Tuchendler,
Grzegorz Madej
Clin Exp HEPATOL 2018; 4, 3: 158–164
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78119
Review paper
A systematic review of the present and future of non-alcoholic fatty liver disease
Christiana Lucas,
Georgia Lucas,
Nicholas Lucas,
Joanna Krzowska-Firych,
Krzysztof Tomasiewicz
Clin Exp HEPATOL 2018; 4, 3: 165–174
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78120
Original paper
Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats
Mohamed A. Ibrahim,
Asmaa Abdel-Aziz,
Azza El-Sheikh,
Maha Kamel,
Al-Zahraa Khalil,
Hisham Abdelhaleem
Clin Exp HEPATOL 2018; 4, 3: 175–181
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78121
Original paper
Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
Abel Abdel-Moneim,
Alaa Abood,
Mohamed Abdel-Gabaar,
Mohamed I. Zanaty,
Mohamed Ramadan
Clin Exp HEPATOL 2018; 4, 3: 191–196
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78123
Original paper
Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma
Adriano Pellicelli,
Valerio Giannelli,
Valerio Zoli,
Valeria Pellicelli,
Anna Linda Zignego
Clin Exp HEPATOL 2018; 4, 3: 197–200
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78124
Short report
Cellulitis in liver cirrhosis – a series of 25 cases from southern India
Uday Sanglodkar,
Mayank Jain,
Dinesh Jothimani,
Subhashree Parida,
Balajee G,
Jayanthi Venkataraman
Clin Exp HEPATOL 2018; 4, 3: 201–204
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78125
Case report
A good response to steroid therapy in IgG4-related sclerosing cholangitis: a case report
Jingqiao Zhang,
Xiaozhong Guo,
Hongyu Li,
Xiaodong Shao,
Jiao Deng,
Zhendong Liang,
Xia Zhang,
Ji Feng,
Hao Lin,
Xingshun Qi
Clin Exp HEPATOL 2018; 4, 3: 205–209
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78126
Case report
Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence
Monika Pazgan-Simon,
Krzysztof A. Simon,
Ewa Jarowicz,
Katarzyna Rotter,
Anna Szymanek-Pasternak,
Jolanta Zuwala-Jagiello
Clin Exp HEPATOL 2018; 4, 3: 210–216
Online publish date: 2018-09-10
DOI
:
https://doi.org/10.5114/ceh.2018.78127
|
